← All trials
NCT04910711
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2021
- Primary completion
- Aug 31, 2023
- Completion date
- Oct 31, 2024
- First posted
- Jun 2, 2021
- Last posted
- Sep 5, 2021
- Enrollment
- 140
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Botswana Harvard Aids InstituteLead sponsor
- University of LiverpoolCollaborator
- Botswana Harvard Aids InstituteReponsible party - principal investigator
- Botswana Harvard Aids InstituteOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.